Keel Point’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $579K | Sell |
1,489
-14
| -0.9% | -$5.45K | 0.04% | 263 |
|
|
2025
Q1 | $654K | Buy |
1,503
+249
| +20% | +$108K | 0.05% | 198 |
|
|
2024
Q4 | $463K | Buy |
1,254
+54
| +5% | +$19.9K | 0.04% | 252 |
|
|
2024
Q3 | $624K | Sell |
1,200
-43
| -3% | -$22.4K | 0.05% | 201 |
|
|
2024
Q2 | $661K | Buy |
1,243
+86
| +7% | +$45.7K | 0.06% | 187 |
|
|
2024
Q1 | $600K | Buy |
1,157
+191
| +20% | +$99.1K | 0.06% | 170 |
|
|
2023
Q4 | $456K | Buy |
966
+34
| +4% | +$16K | 0.05% | 194 |
|
|
2023
Q3 | $406K | Buy |
932
+86
| +10% | +$37.5K | 0.06% | 189 |
|
|
2023
Q2 | $376K | Buy |
846
+30
| +4% | +$13.3K | 0.05% | 207 |
|
|
2023
Q1 | $375K | Sell |
816
-42
| -5% | -$19.3K | 0.05% | 197 |
|
|
2022
Q4 | $440K | Buy |
858
+45
| +6% | +$23.1K | 0.07% | 179 |
|
|
2022
Q3 | $369K | Buy |
813
+1
| +0.1% | +$454 | 0.06% | 169 |
|
|
2022
Q2 | $391K | Sell |
812
-14
| -2% | -$6.74K | 0.06% | 171 |
|
|
2022
Q1 | $406K | Buy |
826
+22
| +3% | +$10.8K | 0.06% | 172 |
|
|
2021
Q4 | $373K | Buy |
804
+51
| +7% | +$23.7K | 0.04% | 179 |
|
|
2021
Q3 | $281K | Buy |
753
+16
| +2% | +$5.97K | 0.04% | 199 |
|
|
2021
Q2 | $281K | Buy |
737
+8
| +1% | +$3.05K | 0.03% | 204 |
|
|
2021
Q1 | $262K | Buy |
729
+92
| +14% | +$33.1K | 0.03% | 214 |
|
|
2020
Q4 | $205K | Buy |
+637
| New | +$205K | 0.02% | 230 |
|